CAPTRUST Financial Advisors
NERV icon

CAPTRUST Financial Advisors’s Minerva Neurosciences NERV Stock Holding History

CAPTRUST Financial Advisors’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-500
Closed -$9K – 4719
2021
Q2 		$9K Buy
+500
New +$10.8K ﹤0.01% 3601

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAPTRUST Financial Advisors's NERV Position: Q3 2021 in Review

CAPTRUST Financial Advisors sold out of Minerva Neurosciences (NERV) in Q3 2021, closing a stake of 500 shares — an estimated $9K sold.

CAPTRUST Financial Advisors first reported a position in NERV in Q2 2021 and held it in 1 quarter. The position peaked at $9K in Q2 2021. 46 funds tracked by Wall St. Rank hold NERV as of Q3 2021.

  • CAPTRUST Financial Advisors reported no remaining Minerva Neurosciences position as of Q3 2021 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 500 Minerva Neurosciences shares in Q3 2021, an estimated $9K.
  • CAPTRUST Financial Advisors first reported a position in Minerva Neurosciences in Q2 2021 and held it in 1 quarter.
  • CAPTRUST Financial Advisors's Minerva Neurosciences position peaked at $9K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.